Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: a retrospective cohort study
These effects are generally mild to moderate in severity and are most common during escalation from lower starting doses
Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron
2026 Jan 31;19:17562864251408269
US$ 20.29
US$ 29.95
US$ 28.87
US$ 24.73
